EMA Begins Safety Review Of Acne Drug Diane 35

A safety review of the acne drug Diane 35 (cyproterone acetate 2 mg, ethinylestradiol 35µg) and its generics has officially begun. The review was started by The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) at its meeting February 4-7 2013. The French medicines regulatory agency (ANSM) requested this Europe-wide review, after stating that they would suspend the permission to advertise Diane 35 and its generics for the treatment of acne in France over the next 3 months... via Health News from Medical News Today Read More Here..